FDA Announces Biosimilar, Prescription Drug User Fees
The FDA began announcing the fee details Monday, beginning with medical devices. The FDA user fee bill signed July 9 authorized the agency to collect $718,669,000 in user fees in the 2013 fiscal year.
Drug sponsors will pay $1,958,800 in the 2013 fiscal year for a full approval application requiring clinical...
To view the full article, register now.